The FDA has granted approval to adjuvant cemiplimab treatment for patients with high-risk cutaneous squamous cell carcinoma ...

Following imlunestrant’s approval, Komal Jhaveri, MD, FACP, compares the oral SERD to its counterpart, elacestrant, in terms of composition and trials.

A network to connect patients with unused medications with patients in need brought $18 million of free cancer medication while reducing drug waste. YesRx CDR Network, a nonprofit network of cancer ...

Subcutaneous daratumumab is well tolerated, but ongoing immune monitoring is key to managing infection risk in patients with ...

The use of ctDNA after surgery can provide guidance to patients who may be receiving input on treatment decisions from every ...

Panelists discuss how the subcutaneous nivolumab data demonstrate reassuring safety with minimal grade 3/4 events, how pharmacokinetic equivalency across varied patient weights supports flat dosing, ...

C, OCN, discusses planning beyond first-line CDK4/6 inhibitors and supportive care strategies for patients with HR+/HER2– ...

AI-driven decision support can ease oncologists’ workloads and streamline care without reducing autonomy.

An LED-based intraoral device for photobiomodulation therapy was safe and reduced severe oral mucositis in patients with head ...

Supportive oncology interventions provide a comprehensive approach to oncology, addressing patients’ needs holistically, which start with understanding a patient’s baseline ne ...

Heather Jackson, PhD, APRN, FNP-BC, NEA-BC, FAA-NP, explains the utility of a holistic approach to oncology care. Comprehensive supportive care requires oncology nurses and advanced practice providers ...